Medicinal Products

763. Deputy Albert Dolan asked the Minister for Health if she will consider introducing sanctions for hospital groups that fail to meet best value medicines uptake requirements, or alternatively strengthening gain-share incentives to ensure the savings target is delivered; and if she will make a statement on the matter. [56635/25]

764. Deputy Albert Dolan asked the Minister for Health the communication and support provided to patients being switched to best value medicines; the monitoring which has been undertaken on patient outcomes and acceptance of switching; and if she will publish the data annually; and if she will make a statement on the matter. [56636/25]

765. Deputy Albert Dolan asked the Minister for Health the way in which the best value medicines programme contributes to reducing the financial burden on the HSE's medicines budget and assists in securing access for patients to new and innovative treatments; and if she will make a statement on the matter. [56637/25]

766. Deputy Albert Dolan asked the Minister for Health if she will report on the progress of the best value medicines programme in achieving its stated target of at least 80% of individuals being in receipt of the best value medicine; if she will provide a breakdown of uptake levels by each target area; and if she will make a statement on the matter. [56638/25]

330. Deputy Aisling Dempsey asked the Minister for Health if she is aware of changes to blister packed medication (details supplied) that will cause difficulties for older persons; and if she will make a statement on the matter. [56086/25]

283. Deputy Duncan Smith asked the Minister for Health to prioritise the provision of the planned online drug payment scheme refund application system to allow online application and document upload capabilities and allow the delivery of refunds by electronic fund transfer; and if she will make a statement on the matter. [55531/25]

305. Deputy Paul Lawless asked the Minister for Health if she will reconsider the decision to introduce a €5 weekly charge per patient for blister pack preparation from January 2026, in light of the impact this will have on elderly patients, many of whom rely on blister packs to safely manage complex medication routines; and if she will make a statement on the matter. [55679/25]

350. Deputy Pádraig Rice asked the Minister for Health the position in relation to a drug (details supplied); if it will be available through the HSE; and if she will make a statement on the matter. [55951/25]

351. Deputy Marie Sherlock asked the Minister for Health the measures her Department is taking to stop novel nicotine products, such as nicotine pearls, from entering and being sold on the marketplace; and if she will make a statement on the matter. [55963/25]

352. Deputy Marie Sherlock asked the Minister for Health the powers she has to prevent novel nicotine products being sold on the market before they have been regulated as genuine tobacco cessation products; and if she will make a statement on the matter. [55964/25]

804. Deputy Danny Healy-Rae asked the Minister for Health for an update on a matter regarding medication (details supplied); and if she will make a statement on the matter. [54593/25]

805. Deputy Michael Healy-Rae asked the Minister for Health if a medication on which a person (details supplied) is dependent which is in short supply and is currently not in stock could be accessed alternatively; and if she will make a statement on the matter. [54595/25]

825. Deputy Seán Ó Fearghaíl asked the Minister for Health if she will consider matters raised correspondence (details supplied) in relation to the funding of dexcom medication for a patient to manage type 1 diabetes; and if she will make a statement on the matter. [54697/25]

873. Deputy Michael Healy-Rae asked the Minister for Health further to Parliamentary Question No. 1161 of 17 September 2025, if Ireland has a stockpile or contingency plan for essential medicines unavailable here (details supplied); and if she will make a statement on the matter. [55111/25]

877. Deputy Ken O'Flynn asked the Minister for Health the steps being taken to address the ongoing shortage of a medication (details supplied), which has now been out of stock for approximately eight months; if she is aware of the impact this shortage is having on long-term patients who have relied on this medication for decades; and if she will confirm when supply is expected to resume. [55143/25…

878. Deputy Ken O'Flynn asked the Minister for Health if contingency arrangements are in place to support patients who have been prescribed alternative medications such as (details supplied), both of which are now also reported to be in short supply, leaving patients without appropriate inhalation therapy; and if she will ensure that the HSE and HPRA work with community pharmacists and wholesalers…

350. Deputy Malcolm Byrne asked the Minister for Health in view of the withdrawal of a medication from the Irish market, if other drugs to replace this medication have been approved by the HSE, including (details supplied); and if she will make a statement on the matter. [54456/25]

315. Deputy Roderic O'Gorman asked the Minister for Health whether the prescription drug Yselty/Linzagolix, used in the treatment of endometriosis, is being considered for inclusion in the drugs treatment scheme; when this process will conclude; and if she will make a statement on the matter. [54088/25]

606. Deputy Richard Boyd Barrett asked the Minister for Health if a medication (details supplied) will be approved for the treatment of Von Hippel-Lindau disease in view of the fact that this medication has EU approval. [53172/25]

683. Deputy Emer Currie asked the Minister for Health whether her Department will include a medication (details supplied) in the drug payment scheme; and if she will make a statement on the matter. [53695/25]

707. Deputy Pádraig Mac Lochlainn asked the Minister for Health the reason the HSE will not fund the prescribing of a medication (details supplied) for the treatment for severe alopecia totalis; and if the HSE have any plans to do so. [53871/25]

89. Deputy Aindrias Moynihan asked the Minister for Health the status on a medication being available on the drugs payment scheme (details supplied); and if she will make a statement on the matter. [52014/25]

102. Deputy Darren O'Rourke asked the Minister for Health when Givinostat will be available to people with Duchenne muscular dystrophy; if cross-border and early access programmes have been considered; and if she will make a statement on the matter. [51163/25]

121. Deputy Mairéad Farrell asked the Minister for Health if she has engaged with the HSE on the recent approval of Belimumab for the treatment of lupus; if funding will be given in budget 2026 towards this treatment; and if she will make a statement on the matter. [52239/25]

452. Deputy Ken O'Flynn asked the Minister for Health the number of oncology drugs approved for use by the European Medicines Agency in each of the years 2020 to 2025; and to specify which of these are currently reimbursed under the public health system, which are only available privately, and the average waiting time from EMA approval to HSE reimbursement. [52823/25]